CSV Life Science Group's European Expansion
CSV Life Science Group's Presence in Europe
From the Nordic countries to Greece, via the Iberian Peninsula: the Group’s European expansion is entering a new phase.
CSV Life Science Group continues to expand across Europe with a clear objective: to be ever closer to its clients and to the strategic markets of the Life Sciences industry.
Building on its well-established presence in Greece through CSV Hellas, the Group has recently expanded further with the launch of CSV Life Science Ibérica, Officially inaugurated in the second quarter of 2026, this new office is dedicated to serving the Spanish and Portuguese markets.
Headquartered in Madrid, CSV Life Science Ibérica has been established to provide direct support to the Iberian Peninsula, ensuring operational proximity, business continuity, and seamless access to the Group’s full ecosystem of expertise and services.
Two Opportunities to Connect with the Spanish Pharma Industry
In May, two events held in Barcellona e Madrid provided valuable opportunities to meet with clients and professionals from the Spanish pharmaceutical sector.
These gatherings represented important moments for dialogue and exchange, allowing us to present the integrated model of CSV Life Science Group while gaining first-hand insight into the needs and expectations of the local market.
The Spanish pharmaceutical industry is dynamic, highly competitive, and increasingly focused on quality. In this environment, regulatory compliance, innovation, and close customer relationships are key factors in successfully supporting new projects.
Strengthening Our Presence Across Northern Europe
The Group’s approach is strategic: establishing a direct presence in key markets in order to build strong, long-lasting relationships with clients.
CSV Life Science Group aims to be a trusted partner capable of combining deep local market knowledge with the extensive international experience gained over more than 25 years of activity.
This vision also underpins the Group’s development strategy across Northern and Central Europe. Through Consseo, Frank Schäfer is closely supporting the markets of Germany, Austria, and Switzerland, while Kristoffer Laursen, through Laspire, will ensure the Group’s presence and tailor-made approach throughout the Nordic region
Frank-Schäfer
Kristoffer Laursen
Our People as Ambassadors of the Group
People, expertise, and values are at the heart of this expansion strategy.
The experience and professionalism of the individuals representing the Group across different markets ensure quality, reliability, and continuity in every engagement.
Their strong alignment with the Group’s values makes them true ambassadors in their respective territories, working side by side with clients every day.
Their role goes beyond representing a portfolio of services; they embody a distinctive way of working built on reliability, accountability, and proactive collaboration.
.
Building an Increasingly Comprehensive Destination Pharma
CSV Life Science Group’s European expansion is part of a broader vision: creating an increasingly widespread and recognizable Destination Pharma.
Bringing an integrated offering to the market means representing the entire pharmaceutical value chain.
This 360-degree model encompasses engineering services, construction, commissioning & qualification, containment solutions, process plant design and implementation, as well as the research, sourcing, and commercialization of Active Pharmaceutical Ingredients (APIs).
This synergy enables us to support and guide complex projects through every stage of their lifecycle.
Pharma, Chemicals and Batteries: Cross-Sector Expertise for Evolving Markets
While maintaining a strong pharmaceutical identity, the Group’s vision extends beyond traditional pharma boundaries.
The high-level expertise developed in regulated pharmaceutical environments naturally translates into the chemical industry and the rapidly evolving battery sector. The latter represents a technological challenge that CSV Life Science Group is fully prepared to embrace.
This growth path is supported by new engineering capabilities and strategic international partnerships, as demonstrated by our close collaboration with a leading German partner possessing deep sector expertise, as well as our active participation in Europe’s premier battery industry event in Stuttgart.
Our ambition is to play a leading role in a market undergoing significant transformation—one that demands technical excellence, industrial vision, and the ability to integrate the most advanced technologies available.
International Growth with a Forward-Looking Vision
The expansion across Europe represents the natural evolution of CSV Life Science Group’s growth journey.
The Group was founded with the goal of integrating diverse areas of expertise. Today, it is increasingly focused on delivering high added value across international markets by combining a strong local presence with a global perspective.
The ability to provide comprehensive turnkey solutions remains one of our core strengths, but our strategy goes far beyond that.
CSV Life Science Group will continue to evolve alongside its clients, supporting them in the emerging landscapes of pharmaceuticals, fine chemicals, and advanced industrial technologies.
Stay connected to discover the Group’s next destinations and follow the next steps in our international growth journey.
Altre news dal mondo CSV
CSV Life Science Group Strengthens Its European Presence
From Northern Europe to the Iberian Peninsula and Greece, the Group continues to grow closer to clients and key Life Sciences markets.
The commitment to the environment of CSV Life Science
Paperless & Digital Validation – CSV Life Science Group is becoming increasingly eco-friendly by transitioning to a digital and paperless validation solution.
